. . "21053555"^^ . . "1704526-12-4" . . . "vaccine"@en . . . . . "Vacuna contra la rub\u00E9ola"@es . "1704526"^^ . "Vaksin rubela adalah vaksin yang digunakan untuk mencegah rubella. Keefektifannya dimulai sekitar dua minggu setelah dosis pertama dan sekitar 95% orang menjadi kebal. Negara dengan tingkat imunisasi tinggi tidak lagi melihat kasus rubella atau sindrom rubela bawaan. Ketika ada tingkat imunisasi anak yang rendah dalam suatu populasi, maka tingkat rubela bawaan mungkin meningkat karena semakin banyak perempuan yang mencapai usia subur tanpa vaksinasi atau paparan terhadap penyakit tersebut. Karena itu, penting bagi lebih dari 80% orang untuk divaksinasi."@in . "\uD48D\uC9C4 \uBC31\uC2E0(\uC601\uC5B4: Rubella vaccine)\uC740 \uD48D\uC9C4\uC5D0 \uAC10\uC5FC\uB418\uC9C0 \uC54A\uAE30 \uC704\uD574 \uC0AC\uC6A9\uD558\uB294 \uBC31\uC2E0\uC774\uB2E4. \uB2E8\uC77C \uC811\uC885\uC73C\uB85C \uC57D 2\uC8FC \uD6C4\uC5D0 \uD6A8\uACFC\uAC00 \uC2DC\uC791\uB418\uBA70, \uC57D 95%\uC758 \uC0AC\uB78C\uC774 \uBA74\uC5ED\uC774 \uD615\uC131\uB41C\uB2E4. \uC608\uBC29 \uC811\uC885\uB960\uC774 \uB192\uC740 \uAD6D\uAC00\uC5D0\uC11C\uB294 \uB354 \uC774\uC0C1 \uD48D\uC9C4\uC774 \uBC1C\uBCD1\uB418\uC9C0 \uC54A\uB294\uB2E4. \uB530\uB77C\uC11C 80% \uC774\uC0C1\uC758 \uC0AC\uB78C\uB4E4\uC774 \uC608\uBC29\uC811\uC885\uC744 \uBC1B\uB294 \uAC83\uC774 \uC911\uC694\uD558\uB2E4. \uC138\uACC4\uBCF4\uAC74\uAE30\uAD6C \uD544\uC218 \uC758\uC57D\uD488 \uBAA9\uB85D\uC5D0 \uD48D\uC9C4 \uBC31\uC2E0\uC774 \uB4F1\uC7AC\uB418\uC5B4 \uC788\uB2E4. \uC8FC\uBCC0 \uC0AC\uB78C\uB4E4\uC774 \uC608\uBC29 \uC811\uC885\uC744 \uBC1B\uC9C0 \uC54A\uC558\uB2E4\uBA74, \uCD5C\uC18C\uD55C \uAC00\uC784\uAE30 \uC5EC\uC131\uC740 \uC608\uBC29\uC811\uC885\uC744 \uBC1B\uB294 \uAC83\uC774 \uC88B\uB2E4."@ko . . "Meruvax, other"@en . "\uD48D\uC9C4 \uBC31\uC2E0"@ko . . . . . . . . . "attenuated"@en . . "Le vaccin contre la rub\u00E9ole est un vaccin destin\u00E9 \u00E0 pr\u00E9venir la rub\u00E9ole, une maladie caus\u00E9e par un virus, le virus de la rub\u00E9ole. L'efficacit\u00E9 du vaccin est importante et ses effets secondaires sont le plus souvent sans gravit\u00E9. Il fait partie des vaccins recommand\u00E9s chez le nourrisson."@fr . "Rubella vaccine is a vaccine used to prevent rubella. Effectiveness begins about two weeks after a single dose and around 95% of people become immune. Countries with high rates of immunization no longer see cases of rubella or congenital rubella syndrome. When there is a low level of childhood immunization in a population it is possible for rates of congenital rubella to increase as more women make it to child-bearing age without either vaccination or exposure to the disease. Therefore, it is important for more than 80% of people to be vaccinated. By introducing rubella containing vaccines, rubella has been eradicated in 81 nations, as of mid-2020. The World Health Organization (WHO) recommends that the rubella vaccine be included in routine vaccinations. If not all people are immunized then at least women of childbearing age should be immunized. It should not be given to those who are pregnant or those with very poor immune function. While one dose is often all that is required for lifelong protection, often two doses are given. Side effects are generally mild. They may include fever, rash, and pain and redness at the site of injection. Joint pain may be reported at between one and three weeks following vaccination in women. Severe allergies are rare. The rubella vaccine is a live attenuated vaccine. It is available either by itself or in combination with other vaccines. Combinations include with measles (MR vaccine), measles and mumps vaccine (MMR vaccine) and measles, mumps and varicella vaccine (MMRV vaccine). A rubella vaccine was first licensed in 1969. It is on the World Health Organization's List of Essential Medicines. As of 2019, more than 173 countries included it in their routine vaccinations."@en . . "17879"^^ . . . . . "\u5FB7\u570B\u9EBB\u75B9\u75AB\u82D7"@zh . . . . . . . . "Rubella vaccine is a vaccine used to prevent rubella. Effectiveness begins about two weeks after a single dose and around 95% of people become immune. Countries with high rates of immunization no longer see cases of rubella or congenital rubella syndrome. When there is a low level of childhood immunization in a population it is possible for rates of congenital rubella to increase as more women make it to child-bearing age without either vaccination or exposure to the disease. Therefore, it is important for more than 80% of people to be vaccinated. By introducing rubella containing vaccines, rubella has been eradicated in 81 nations, as of mid-2020."@en . . "1124262143"^^ . . . . . . . . . . "\u0644\u0642\u0627\u062D \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629"@ar . . . "none"@en . . "Vaccino anti-rosolia"@it . . . . . . . . . . "changed"@en . "\u03A4\u03BF \u03B5\u03BC\u03B2\u03CC\u03BB\u03B9\u03BF \u03C4\u03B7\u03C2 \u03B5\u03C1\u03C5\u03B8\u03C1\u03AC\u03C2 \u03B5\u03AF\u03BD\u03B1\u03B9 \u03AD\u03BD\u03B1 \u03B5\u03BC\u03B2\u03CC\u03BB\u03B9\u03BF \u03C0\u03BF\u03C5 \u03C7\u03C1\u03B7\u03C3\u03B9\u03BC\u03BF\u03C0\u03BF\u03B9\u03B5\u03AF\u03C4\u03B1\u03B9 \u03B3\u03B9\u03B1 \u03C4\u03B7\u03BD \u03C0\u03C1\u03CC\u03BB\u03B7\u03C8\u03B7 \u03C4\u03B7\u03C2 \u03B5\u03C1\u03C5\u03B8\u03C1\u03AC\u03C2. \u0397 \u03B1\u03C0\u03BF\u03C4\u03B5\u03BB\u03B5\u03C3\u03BC\u03B1\u03C4\u03B9\u03BA\u03CC\u03C4\u03B7\u03C4\u03B1 \u03BE\u03B5\u03BA\u03B9\u03BD\u03AC \u03C0\u03B5\u03C1\u03AF\u03C0\u03BF\u03C5 \u03B4\u03CD\u03BF \u03B5\u03B2\u03B4\u03BF\u03BC\u03AC\u03B4\u03B5\u03C2 \u03BC\u03B5\u03C4\u03AC \u03B1\u03C0\u03CC \u03BC\u03AF\u03B1 \u03B5\u03C6\u03AC\u03C0\u03B1\u03BE \u03B4\u03CC\u03C3\u03B7, \u03B5\u03BD\u03CE \u03B1\u03BD\u03BF\u03C3\u03AF\u03B1 \u03B1\u03C0\u03BF\u03BA\u03C4\u03AC \u03C0\u03B5\u03C1\u03AF\u03C0\u03BF\u03C5 \u03C4\u03BF 95% \u03C4\u03C9\u03BD \u03B1\u03C4\u03CC\u03BC\u03C9\u03BD. \u03A3\u03B5 \u03C7\u03CE\u03C1\u03B5\u03C2 \u03BC\u03B5 \u03C5\u03C8\u03B7\u03BB\u03AC \u03C0\u03BF\u03C3\u03BF\u03C3\u03C4\u03AC \u03B1\u03BD\u03BF\u03C3\u03BF\u03C0\u03BF\u03AF\u03B7\u03C3\u03B7\u03C2 \u03B4\u03B5\u03BD \u03B5\u03BC\u03C6\u03B1\u03BD\u03AF\u03B6\u03BF\u03BD\u03C4\u03B1\u03B9 \u03C0\u03BB\u03AD\u03BF\u03BD \u03C0\u03B5\u03C1\u03B9\u03C0\u03C4\u03CE\u03C3\u03B5\u03B9\u03C2 \u03B5\u03C1\u03C5\u03B8\u03C1\u03AC\u03C2 \u03AE . \u038C\u03C4\u03B1\u03BD \u03C4\u03BF \u03B5\u03C0\u03AF\u03C0\u03B5\u03B4\u03BF \u03C4\u03B7\u03C2 \u03C0\u03B1\u03B9\u03B4\u03B9\u03BA\u03AE\u03C2 \u03B1\u03BD\u03BF\u03C3\u03BF\u03C0\u03BF\u03AF\u03B7\u03C3\u03B7\u03C2 \u03C3\u03B5 \u03AD\u03BD\u03B1\u03BD \u03C0\u03BB\u03B7\u03B8\u03C5\u03C3\u03BC\u03CC \u03B5\u03AF\u03BD\u03B1\u03B9 \u03C7\u03B1\u03BC\u03B7\u03BB\u03CC, \u03C4\u03B1 \u03C0\u03BF\u03C3\u03BF\u03C3\u03C4\u03AC \u03C3\u03C5\u03B3\u03B3\u03B5\u03BD\u03BF\u03CD\u03C2 \u03B5\u03C1\u03C5\u03B8\u03C1\u03AC\u03C2 \u03B5\u03BD\u03B4\u03AD\u03C7\u03B5\u03C4\u03B1\u03B9 \u03BD\u03B1 \u03B1\u03C5\u03BE\u03B7\u03B8\u03BF\u03CD\u03BD, \u03BA\u03B1\u03B8\u03CE\u03C2 \u03BF\u03B9 \u03C0\u03B5\u03C1\u03B9\u03C3\u03C3\u03CC\u03C4\u03B5\u03C1\u03B5\u03C2 \u03B3\u03C5\u03BD\u03B1\u03AF\u03BA\u03B5\u03C2 \u03C6\u03C4\u03AC\u03BD\u03BF\u03C5\u03BD \u03C3\u03C4\u03B7\u03BD \u03B1\u03BD\u03B1\u03C0\u03B1\u03C1\u03B1\u03B3\u03C9\u03B3\u03B9\u03BA\u03AE \u03B7\u03BB\u03B9\u03BA\u03AF\u03B1 \u03C7\u03C9\u03C1\u03AF\u03C2 \u03BD\u03B1 \u03AD\u03C7\u03BF\u03C5\u03BD \u03B5\u03BC\u03B2\u03BF\u03BB\u03B9\u03B1\u03C3\u03C4\u03B5\u03AF \u03AE \u03BD\u03B1 \u03AD\u03C7\u03BF\u03C5\u03BD \u03B5\u03BA\u03C4\u03B5\u03B8\u03B5\u03AF \u03C3\u03C4\u03B7\u03BD \u03B1\u03C3\u03B8\u03AD\u03BD\u03B5\u03B9\u03B1. \u03A9\u03C2 \u03B5\u03BA \u03C4\u03BF\u03CD\u03C4\u03BF\u03C5, \u03B5\u03AF\u03BD\u03B1\u03B9 \u03C3\u03B7\u03BC\u03B1\u03BD\u03C4\u03B9\u03BA\u03CC \u03BD\u03B1 \u03B5\u03BC\u03B2\u03BF\u03BB\u03B9\u03AC\u03B6\u03B5\u03C4\u03B1\u03B9 \u03C0\u03BF\u03C3\u03BF\u03C3\u03C4\u03CC \u03BC\u03B5\u03B3\u03B1\u03BB\u03CD\u03C4\u03B5\u03C1\u03BF \u03B1\u03C0\u03CC \u03C4\u03BF 80% \u03C4\u03BF\u03C5 \u03C0\u03BB\u03B7\u03B8\u03C5\u03C3\u03BC\u03BF\u03CD."@el . . . . "Il vaccino della rosolia \u00E8 un vaccino che viene utilizzato per prevenire la rosolia. Il vaccino richiede all'incirca due settimane per essere efficace, ed una singola dose \u00E8 sufficiente a rendere immune circa il 95% dei soggetti. Nei paesi che presentano alti tassi di immunizzazione non sono pi\u00F9 presenti casi di rosolia di nuova insorgenza, o di sindrome da rosolia congenita. Laddove il tasso di immunizzazione infantile \u00E8 invece basso, il numero di casi di rosolia congenita \u00E8 destinato ad incrementare per via dell'aumentato numero di donne che raggiungono l'et\u00E0 fertile senza essere state prima vaccinate o esposte al contagio. \u00C8 quindi raccomandato che a ricevere il vaccino sia almeno l'80% della popolazione."@it . "R\u00F6telnimpfstoff"@de . "\u0644\u0642\u0627\u062D \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: \u0644\u0642\u0627\u062D \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629)\u0647\u0648 \u0644\u0642\u0627\u062D \u064A\u0633\u062A\u062E\u062F\u0645 \u0644\u0644\u0648\u0642\u0627\u064A\u0629 \u0645\u0646 \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629. \u062A\u0628\u062F\u0623 \u0641\u0639\u0627\u0644\u064A\u062A\u0647 \u0628\u0639\u062F \u0623\u0633\u0628\u0648\u0639\u064A\u0646 \u0645\u0646 \u0627\u0644\u062C\u0631\u0639\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 \u0648\u062A\u0642\u0631\u064A\u0628\u0627\u064F 95% \u0645\u0646 \u0627\u0644\u0623\u0634\u062E\u0627\u0635 \u064A\u0635\u0628\u062D\u0648\u0627 \u0645\u062D\u0635\u0646\u064A\u0646 \u0636\u062F \u0627\u0644\u0639\u062F\u0648\u0649. \u0627\u0644\u0628\u0644\u062F\u0627\u0646 \u0630\u0627\u062A \u0645\u0639\u062F\u0644\u0627\u062A \u0627\u0644\u062A\u062D\u0635\u064A\u0646 \u0627\u0644\u0645\u0631\u062A\u0641\u0639\u0629 \u0644\u0645 \u062A\u0639\u062F \u062A\u0631\u0649 \u062D\u0627\u0644\u0627\u062A \u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 \u0623\u0648 \u0645\u062A\u0644\u0627\u0632\u0645\u0629 \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 \u0627\u0644\u062E\u0644\u0642\u064A\u0629. \u0639\u0646\u062F\u0645\u0627 \u064A\u0643\u0648\u0646 \u0645\u0633\u062A\u0648\u0649 \u0627\u0644\u0645\u0646\u0627\u0639\u0629 \u0636\u062F \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 \u0639\u0646\u062F \u0627\u0644\u0623\u0637\u0641\u0627\u0644 \u0645\u0646\u062E\u0641\u0636 \u0645\u0646 \u0627\u0644\u0645\u062D\u062A\u0645\u0644 \u0623\u0646 \u062A\u0631\u062A\u0641\u0639 \u0645\u0639\u062F\u0644\u0627\u062A \u0627\u0644\u0635\u0627\u0628\u0629 \u0628\u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 \u0627\u0644\u062E\u0644\u0642\u064A\u0629 \u062C\u064A\u062B \u064A\u0632\u062F\u0627\u062F \u0639\u062F\u062F \u0627\u0644\u0646\u0633\u0627\u0621 \u0627\u0644\u0644\u0648\u0627\u062A\u064A \u064A\u0635\u0644\u0646 \u0644\u0633\u0646 \u0627\u0644\u0625\u0646\u062C\u0627\u0628 \u062F\u0648\u0646 \u0623\u062E\u062F \u0627\u0644\u062A\u0637\u0639\u064A\u0645 \u0623\u0648 \u0627\u0644\u062A\u0639\u0631\u0636 \u0644\u0644\u0645\u0631\u0636. \u0644\u0630\u0644\u0643\u060C \u0645\u0646 \u0627\u0644\u0645\u0647\u0645 \u0623\u0646 \u064A\u0643\u0648\u0646 \u0623\u0643\u062B\u0631 \u0645\u0646 80% \u0645\u0646 \u0627\u0644\u0646\u0627\u0633 \u062A\u0645 \u062A\u0637\u0639\u064A\u0645\u0647\u0645.\u0623\u0648\u0635\u062A \u0645\u0646\u0638\u0645\u0629 \u0627\u0644\u0635\u062D\u0629 \u0627\u0644\u0639\u0627\u0644\u0645\u064A\u0629 \u0628\u0625\u062F\u0631\u0627\u062C \u0644\u0642\u0627\u062D \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 \u0636\u0645\u0646 \u0627\u0644\u0644\u0642\u0627\u062D\u0627\u062A \u0627\u0644\u0631\u0648\u062A\u064A\u0646\u064A\u0629. \u0625\u0630\u0627 \u0644\u0645 \u064A\u062A\u0645 \u062A\u0637\u0639\u064A\u0645 \u062C\u0645\u064A\u0639 \u0627\u0644\u0646\u0627\u0633 \u0639\u0644\u0649 \u0627\u0644\u0623\u0642\u0644 \u064A\u062C\u0628 \u062A\u0637\u0639\u064A\u0645 \u0627\u0644\u0646\u0633\u0627\u0621 \u0641\u064A \u0633\u0646 \u0627\u0644\u0625\u0646\u062C\u0627\u0628. \u0648\u0644\u0627 \u064A\u062C\u0628 \u0623\u0639\u0637\u0627\u0626\u0647 \u0644\u0644\u0646\u0633\u0627\u0621 \u062E\u0644\u0627\u0644 \u0627\u0644\u062D\u0645\u0644 \u0623\u0648 \u0627\u0644\u0623\u0634\u062E\u0627\u0635 \u0630\u0648\u064A \u0627\u0644\u0645\u0646\u0627\u0639\u0629 \u0627\u0644\u0636\u0639\u064A\u0641\u0629. \u0628\u064A\u0646\u0645\u0627 \u062A\u0643\u0641\u064A \u062C\u0631\u0639\u0629 \u0648\u0627\u062D\u062F\u0629 \u0639\u0627\u062F\u0629\u064B \u0644\u062A\u0648\u0641\u064A\u0631 \u0627\u0644\u062D\u0645\u0627\u064A\u0629 \u0644\u0645\u062F\u0649 \u0627\u0644\u062D\u064A\u0627\u0629\u060C \u0639\u0627\u062F\u0629 \u064A\u062A\u0645 \u0625\u0639\u0637\u0627\u0621 \u062C\u0631\u0639\u062A\u064A\u0646.\u062A\u0639\u062F \u0627\u0644\u0623\u062B\u0627\u0631 \u0627\u0644\u062C\u0627\u0646\u0628\u064A\u0629 \u062E\u0641\u064A\u0641\u0629 \u0628\u0634\u0643\u0644 \u0639\u0627\u0645. \u062A\u0634\u0645\u0644: \u0627\u0644\u062D\u0645\u0649, \u0627\u0644\u0637\u0641\u062D \u0627\u0644\u062C\u0644\u062F\u064A, \u0627\u0644\u0623\u0644\u0645, \u0648\u0627\u0644\u0627\u062D\u0645\u0631\u0627\u0631 \u0639\u0646\u062F \u0645\u0648\u0642\u0639 \u0627\u0644\u062D\u0642\u0646. \u064A\u0645\u0643\u0646 \u0623\u0646 \u062A\u0628\u0644\u063A \u0628\u0639\u0636 \u0627\u0644\u0646\u0633\u0627\u0621 \u0639\u0646 \u0623\u0644\u0645 \u0641\u064A \u0627\u0644\u0645\u0641\u0627\u0635\u0644 \u0628\u0639\u062F 1-3 \u0623\u0633\u0627\u0628\u064A\u0639 \u0645\u0646 \u0627\u0644\u062A\u0637\u0639\u064A\u0645. \u062A\u0639\u062F \u0627\u0644\u062D\u0633\u0627\u0633\u064A\u0629 \u0627\u0644\u0634\u062F\u064A\u062F\u0629 \u0646\u0627\u062F\u0631\u0629 \u0627\u0644\u062D\u062F\u0648\u062B. \u0644\u0642\u0627\u062D \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 \u064A\u0639\u062F \u0644\u0642\u0627\u062D \u0645\u0648\u0647\u0651\u0646 \u062D\u064A. \u0648\u064A\u062A\u0648\u0641\u0631 \u0625\u0645\u0627 \u0628\u0645\u0641\u0631\u062F\u0647 \u0623\u0648 \u0636\u0645\u0646 \u062A\u0631\u0643\u064A\u0628\u0629 \u0645\u0639 \u0644\u0642\u0627\u062D\u0627\u062A \u0623\u062E\u0631\u0649. \u062A\u0634\u0645\u0644 \u0627\u0644\u062A\u0631\u0643\u064A\u0628\u0627\u062A \u0644\u0642\u0627\u062D \u0627\u0644\u062D\u0635\u0628\u0629 \u0648 \u0627\u0644\u0646\u0643\u0627\u0641(MMR vaccine)\u0648 \u0644\u0642\u0627\u062D \u0627\u0644\u062D\u0635\u0628\u0629 \u0648\u0627\u0644\u0646\u0643\u0627\u0641 \u0648\u062C\u062F\u0631\u064A \u0627\u0644\u0645\u0627\u0621 (MMRV vaccine). \u062A\u0645 \u062A\u0631\u062E\u064A\u0635 \u0644\u0642\u0627\u062D \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 \u0644\u0623\u0648\u0644 \u0645\u0631\u0629 \u0641\u064A \u0639\u0627\u0645 1969. \u0648\u0647\u0648 \u0645\u062F\u0631\u062C \u0636\u0645\u0646 \u0642\u0627\u0626\u0645\u0629 \u0627\u0644\u0623\u062F\u0648\u064A\u0629 \u0627\u0644\u0623\u0633\u0627\u0633\u064A\u0629 \u0644\u0645\u0646\u0638\u0645\u0629 \u0627\u0644\u0635\u062D\u0629 \u0627\u0644\u0639\u0627\u0644\u0645\u064A\u0629\u060C \u0648\u0647\u064A \u0627\u0644\u0623\u062F\u0648\u064A\u0629 \u0627\u0644\u0623\u0643\u062B\u0631 \u0641\u0639\u0627\u0644\u064A\u0629 \u0648\u0623\u0645\u0627\u0646 \u0648\u0636\u0631\u0648\u0631\u064A\u0629 \u0641\u064A \u0627\u0644\u0646\u0638\u0627\u0645 \u0627\u0644\u0635\u062D\u064A. \u0627\u0639\u062A\u0628\u0627\u0631\u0627\u064B \u0645\u0646 \u0639\u0627\u0645 2009 \u0623\u0643\u062B\u0631 \u0645\u0646 130 \u062F\u0648\u0644\u0629 \u0623\u062F\u0631\u062C\u062A \u0644\u0642\u0627\u062D \u0627\u0644\u062D\u062B\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 \u0636\u0645\u0646 \u0627\u0644\u062A\u0637\u0639\u064A\u0645\u0627\u062A \u0627\u0644\u0631\u0648\u062A\u064A\u0646\u064A\u0629. \u062A\u0643\u0644\u0641\u0629 \u0628\u064A\u0639 \u0627\u0644\u062C\u0645\u0644\u0629 \u0644\u0642\u0627\u062D \u0645\u0631 \u0644\u064F\u0642\u0627\u062D MMR \u0641\u064A \u0627\u0644\u0639\u0627\u0644\u0645 \u0627\u0644\u0646\u0627\u0645\u064A \u0647\u0648 0.24 \u062F\u0648\u0644\u0627\u0631 \u0623\u0645\u0631\u064A\u0643\u064A \u0644\u0644\u062C\u0631\u0639\u0629 \u0627\u0639\u062A\u0628\u0627\u0631\u0627\u064B \u0645\u0646 \u0639\u0627\u0645 2014.\u0648\u0641\u064A \u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u064A\u062A\u0631\u0627\u0648\u062D \u0628\u064A\u0646 50 \u0648 100 \u062F\u0648\u0644\u0627\u0631 \u0623\u0645\u0631\u064A\u0643\u064A."@ar . "\u0395\u03BC\u03B2\u03CC\u03BB\u03B9\u03BF \u03C4\u03B7\u03C2 \u03B5\u03C1\u03C5\u03B8\u03C1\u03AC\u03C2"@el . "J07"@en . . "446098234"^^ . . "a601176"@en . . . "\u98A8\u75B9\u30EF\u30AF\u30C1\u30F3\uFF08\u3075\u3046\u3057\u3093\u30EF\u30AF\u30C1\u30F3\uFF09\u3068\u306F\u3001\u98A8\u75B9\u306E\u4E88\u9632\u306B\u7528\u3044\u3089\u308C\u308B\u30EF\u30AF\u30C1\u30F3\u3067\u3042\u308B\u3002"@ja . . . "Ein R\u00F6telnimpfstoff ist ein Lebendimpfstoff gegen Infektionen mit dem R\u00F6telnvirus (RuV). Der R\u00F6telnimpfstoff befindet sich auf der Liste der unentbehrlichen Arzneimittel der Weltgesundheitsorganisation."@de . . "Le vaccin contre la rub\u00E9ole est un vaccin destin\u00E9 \u00E0 pr\u00E9venir la rub\u00E9ole, une maladie caus\u00E9e par un virus, le virus de la rub\u00E9ole. L'efficacit\u00E9 du vaccin est importante et ses effets secondaires sont le plus souvent sans gravit\u00E9. Il fait partie des vaccins recommand\u00E9s chez le nourrisson."@fr . . . . . "A vacina antirrub\u00E9ola \u00E9 uma vacina usada para prevenir a rub\u00E9ola. Os efeitos s\u00E3o vis\u00EDveis cerca de duas semanas depois duma \u00FAnica dose, e cerca de 95% das pessoas tornam-se imunes. Sendo a rub\u00E9ola uma doen\u00E7a imunopreven\u00EDvel, a vacina\u00E7\u00E3o \u00E9 a medida indicada para o controle, elimina\u00E7\u00E3o ou erradica\u00E7\u00E3o da rub\u00E9ola e da s\u00EDndrome da rub\u00E9ola cong\u00E9nita. Quando existe um baixo n\u00EDvel de imuniza\u00E7\u00E3o infantil numa popula\u00E7\u00E3o \u00E9 poss\u00EDvel que os \u00EDndices de rub\u00E9ola cong\u00E9nita aumentem \u00E0 medida que mais mulheres se encontram em idade reprodutiva sem vacina\u00E7\u00E3o ou expostas \u00E0 doen\u00E7a. Portanto, \u00E9 importante que mais de 80% de pessoas sejam vacinadas."@pt . "Meruvax, other"@en . . . "La vacuna contra la rub\u00E9ola es una vacuna que se usa para prevenir la rub\u00E9ola.\u200B La efectividad comienza aproximadamente dos semanas despu\u00E9s de una dosis \u00FAnica y alrededor del 95% de las personas se vuelven inmunes. Los pa\u00EDses con altas tasas de inmunizaci\u00F3n ya no ven casos de rub\u00E9ola o s\u00EDndrome de rub\u00E9ola cong\u00E9nita. Cuando hay un bajo nivel de inmunizaci\u00F3n infantil en una poblaci\u00F3n, es posible que las tasas de rub\u00E9ola cong\u00E9nita aumenten a medida que m\u00E1s mujeres llegan a la edad f\u00E9rtil sin la vacunaci\u00F3n o la exposici\u00F3n a la enfermedad. Por lo tanto, es importante que m\u00E1s del 80% de las personas se vacunen."@es . . "Ein R\u00F6telnimpfstoff ist ein Lebendimpfstoff gegen Infektionen mit dem R\u00F6telnvirus (RuV). Der R\u00F6telnimpfstoff befindet sich auf der Liste der unentbehrlichen Arzneimittel der Weltgesundheitsorganisation."@de . "La vacuna contra la rub\u00E9ola es una vacuna que se usa para prevenir la rub\u00E9ola.\u200B La efectividad comienza aproximadamente dos semanas despu\u00E9s de una dosis \u00FAnica y alrededor del 95% de las personas se vuelven inmunes. Los pa\u00EDses con altas tasas de inmunizaci\u00F3n ya no ven casos de rub\u00E9ola o s\u00EDndrome de rub\u00E9ola cong\u00E9nita. Cuando hay un bajo nivel de inmunizaci\u00F3n infantil en una poblaci\u00F3n, es posible que las tasas de rub\u00E9ola cong\u00E9nita aumenten a medida que m\u00E1s mujeres llegan a la edad f\u00E9rtil sin la vacunaci\u00F3n o la exposici\u00F3n a la enfermedad. Por lo tanto, es importante que m\u00E1s del 80% de las personas se vacunen. La Organizaci\u00F3n Mundial de la Salud (OMS) recomend\u00F3 que la vacuna contra la rub\u00E9ola se incluyera en los . Si no todas las personas est\u00E1n inmunizadas, al menos las mujeres en edad f\u00E9rtil deben ser inmunizadas. No debe administrarse a las mujeres embarazadas o con una funci\u00F3n inmunol\u00F3gica muy deficiente. Mientras que una dosis es a menudo todo lo que se requiere para una protecci\u00F3n de por vida, a menudo se administran dos dosis. Los efectos secundarios son generalmente leves. Pueden incluir fiebre, erupci\u00F3n cut\u00E1nea, dolor y enrojecimiento en el lugar de la inyecci\u00F3n. El dolor articular se puede reportar entre una y tres semanas despu\u00E9s de la vacunaci\u00F3n en mujeres. Las alergias severas son raras. La vacuna contra la rub\u00E9ola es una vacuna viva atenuada. Est\u00E1 disponible ya sea sola o en combinaci\u00F3n con otras vacunas. Las combinaciones incluyen con la del sarampi\u00F3n (vacuna MR), la vacuna contra el sarampi\u00F3n y las paperas (vacuna MMR) y la vacuna contra el sarampi\u00F3n, las paperas y la varicela (vacuna MMRV). Una vacuna contra la rub\u00E9ola se autoriz\u00F3 por primera vez en 1969.\u200B Est\u00E1 en la Lista de medicamentos esenciales de la Organizaci\u00F3n Mundial de la Salud, los medicamentos m\u00E1s efectivos y seguros que se necesitan en un sistema de salud.\u200B A partir de 2009, m\u00E1s de 130 pa\u00EDses lo incluyeron en sus vacunas de rutina. El costo al por mayor de la vacuna MMR en el mundo en desarrollo es de US$0,24 por dosis para el a\u00F1o 2014.\u200B En los Estados Unidos cuesta entre US$50 y 100.\u200B"@es . . . . . . "Vacina antirrub\u00E9ola"@pt . . . "Vaksin rubela adalah vaksin yang digunakan untuk mencegah rubella. Keefektifannya dimulai sekitar dua minggu setelah dosis pertama dan sekitar 95% orang menjadi kebal. Negara dengan tingkat imunisasi tinggi tidak lagi melihat kasus rubella atau sindrom rubela bawaan. Ketika ada tingkat imunisasi anak yang rendah dalam suatu populasi, maka tingkat rubela bawaan mungkin meningkat karena semakin banyak perempuan yang mencapai usia subur tanpa vaksinasi atau paparan terhadap penyakit tersebut. Karena itu, penting bagi lebih dari 80% orang untuk divaksinasi. Organisasi Kesehatan Dunia (WHO) menyarankan agar vaksin rubela dimasukkan dalam vaksinasi rutin. Jika tidak semua orang diimunisasi maka setidaknya wanita usia subur harus diimunisasi. Seharusnya tidak diberikan kepada mereka yang sedang hamil atau mereka yang memiliki fungsi kekebalan tubuh yang sangat buruk. Sementara satu dosis sering yang diperlukan untuk semua perlindungan seumur hidup, sering kali dua dosis diberikan."@in . "A vacina antirrub\u00E9ola \u00E9 uma vacina usada para prevenir a rub\u00E9ola. Os efeitos s\u00E3o vis\u00EDveis cerca de duas semanas depois duma \u00FAnica dose, e cerca de 95% das pessoas tornam-se imunes. Sendo a rub\u00E9ola uma doen\u00E7a imunopreven\u00EDvel, a vacina\u00E7\u00E3o \u00E9 a medida indicada para o controle, elimina\u00E7\u00E3o ou erradica\u00E7\u00E3o da rub\u00E9ola e da s\u00EDndrome da rub\u00E9ola cong\u00E9nita. Quando existe um baixo n\u00EDvel de imuniza\u00E7\u00E3o infantil numa popula\u00E7\u00E3o \u00E9 poss\u00EDvel que os \u00EDndices de rub\u00E9ola cong\u00E9nita aumentem \u00E0 medida que mais mulheres se encontram em idade reprodutiva sem vacina\u00E7\u00E3o ou expostas \u00E0 doen\u00E7a. Portanto, \u00E9 importante que mais de 80% de pessoas sejam vacinadas. Para metas de elimina\u00E7\u00E3o da rub\u00E9ola e da s\u00EDndrome da rub\u00E9ola cong\u00E9nita, as mulheres em idade reprodutiva passaram a ser alvo das campanhas de imuniza\u00E7\u00E3o contra rub\u00E9ola incorporadas \u00E0s recomenda\u00E7\u00F5es da Organiza\u00E7\u00E3o Mundial de Sa\u00FAde (OMS), que aconselha integrar a vacina em programas de rotina, que permitem detectar e responder rapidamente aos surtos valendo-se de estrat\u00E9gias de conten\u00E7\u00E3o. Se nem todas as pessoas forem imunizadas, \u00E9 importante que pelo menos as mulheres em idade f\u00E9rtil o sejam. A vacina n\u00E3o deve ser administrada naquelas em per\u00EDodo de gesta\u00E7\u00E3o ou em pessoas com um sistema imunol\u00F3gico muito fraco. Apesar de uma dose ser geralmente o quanto baste para uma protec\u00E7\u00E3o vital\u00EDcia, normalmente \u00E9 oferecida uma segunda oportunidade de vacina\u00E7\u00E3o por meio de campanhas para controlar e reduzir o ac\u00FAmulo de suscet\u00EDveis e prevenir os casos importados. As reac\u00E7\u00F5es p\u00F3s-vacinais normalmente s\u00E3o ligeiras. Podem incluir febre, erup\u00E7\u00E3o cut\u00E2nea ou dor e vermelhid\u00E3o no local da injec\u00E7\u00E3o. Em mulheres pode-se correlacionar dor nas articula\u00E7\u00F5es dentro de uma e tr\u00EAs semanas depois da vacina\u00E7\u00E3o. Podem tamb\u00E9m ocorrer casos espor\u00E1dicos de alergias graves. A vacina antirrub\u00E9ola \u00E9 fabricada a partir de estirpes virais vivas atenuadas da rub\u00E9ola. Encontra-se dispon\u00EDvel como vacina monovalente ou combinada com outras vacinas. Isso inclui as vacinas multivalentes que cont\u00EAm tamb\u00E9m o v\u00EDrus do sarampo e parotidite (vacina VASPR) e multivalentes contendo o v\u00EDrus do sarampo, papeira, rub\u00E9ola e/ou varicela. (VASPRV). A vacina contra a rub\u00E9ola foi pela primeira vez autorizada em 1969. Consta na Lista de Medicamentos Essenciais da Organiza\u00E7\u00E3o Mundial de Sa\u00FAde, considerados os mais eficazes e seguros para responder \u00E0s necessidades de um sistema de sa\u00FAde b\u00E1sico. Desde 2009 que mais de 130 pa\u00EDses a integram nas vacinas de rotina. O pre\u00E7o de venda da vacina tr\u00EDplice viral no mundo em desenvolvimento era de 0,24 d\u00F3lares por americanos por dose, em 2014. Nos Estados Unidos custa entre 50 e 100 USD."@pt . . . . "MMR vaccine contains rubella vaccine"@en . . . "Rubella vaccine"@en . . "\u03A4\u03BF \u03B5\u03BC\u03B2\u03CC\u03BB\u03B9\u03BF \u03C4\u03B7\u03C2 \u03B5\u03C1\u03C5\u03B8\u03C1\u03AC\u03C2 \u03B5\u03AF\u03BD\u03B1\u03B9 \u03AD\u03BD\u03B1 \u03B5\u03BC\u03B2\u03CC\u03BB\u03B9\u03BF \u03C0\u03BF\u03C5 \u03C7\u03C1\u03B7\u03C3\u03B9\u03BC\u03BF\u03C0\u03BF\u03B9\u03B5\u03AF\u03C4\u03B1\u03B9 \u03B3\u03B9\u03B1 \u03C4\u03B7\u03BD \u03C0\u03C1\u03CC\u03BB\u03B7\u03C8\u03B7 \u03C4\u03B7\u03C2 \u03B5\u03C1\u03C5\u03B8\u03C1\u03AC\u03C2. \u0397 \u03B1\u03C0\u03BF\u03C4\u03B5\u03BB\u03B5\u03C3\u03BC\u03B1\u03C4\u03B9\u03BA\u03CC\u03C4\u03B7\u03C4\u03B1 \u03BE\u03B5\u03BA\u03B9\u03BD\u03AC \u03C0\u03B5\u03C1\u03AF\u03C0\u03BF\u03C5 \u03B4\u03CD\u03BF \u03B5\u03B2\u03B4\u03BF\u03BC\u03AC\u03B4\u03B5\u03C2 \u03BC\u03B5\u03C4\u03AC \u03B1\u03C0\u03CC \u03BC\u03AF\u03B1 \u03B5\u03C6\u03AC\u03C0\u03B1\u03BE \u03B4\u03CC\u03C3\u03B7, \u03B5\u03BD\u03CE \u03B1\u03BD\u03BF\u03C3\u03AF\u03B1 \u03B1\u03C0\u03BF\u03BA\u03C4\u03AC \u03C0\u03B5\u03C1\u03AF\u03C0\u03BF\u03C5 \u03C4\u03BF 95% \u03C4\u03C9\u03BD \u03B1\u03C4\u03CC\u03BC\u03C9\u03BD. \u03A3\u03B5 \u03C7\u03CE\u03C1\u03B5\u03C2 \u03BC\u03B5 \u03C5\u03C8\u03B7\u03BB\u03AC \u03C0\u03BF\u03C3\u03BF\u03C3\u03C4\u03AC \u03B1\u03BD\u03BF\u03C3\u03BF\u03C0\u03BF\u03AF\u03B7\u03C3\u03B7\u03C2 \u03B4\u03B5\u03BD \u03B5\u03BC\u03C6\u03B1\u03BD\u03AF\u03B6\u03BF\u03BD\u03C4\u03B1\u03B9 \u03C0\u03BB\u03AD\u03BF\u03BD \u03C0\u03B5\u03C1\u03B9\u03C0\u03C4\u03CE\u03C3\u03B5\u03B9\u03C2 \u03B5\u03C1\u03C5\u03B8\u03C1\u03AC\u03C2 \u03AE . \u038C\u03C4\u03B1\u03BD \u03C4\u03BF \u03B5\u03C0\u03AF\u03C0\u03B5\u03B4\u03BF \u03C4\u03B7\u03C2 \u03C0\u03B1\u03B9\u03B4\u03B9\u03BA\u03AE\u03C2 \u03B1\u03BD\u03BF\u03C3\u03BF\u03C0\u03BF\u03AF\u03B7\u03C3\u03B7\u03C2 \u03C3\u03B5 \u03AD\u03BD\u03B1\u03BD \u03C0\u03BB\u03B7\u03B8\u03C5\u03C3\u03BC\u03CC \u03B5\u03AF\u03BD\u03B1\u03B9 \u03C7\u03B1\u03BC\u03B7\u03BB\u03CC, \u03C4\u03B1 \u03C0\u03BF\u03C3\u03BF\u03C3\u03C4\u03AC \u03C3\u03C5\u03B3\u03B3\u03B5\u03BD\u03BF\u03CD\u03C2 \u03B5\u03C1\u03C5\u03B8\u03C1\u03AC\u03C2 \u03B5\u03BD\u03B4\u03AD\u03C7\u03B5\u03C4\u03B1\u03B9 \u03BD\u03B1 \u03B1\u03C5\u03BE\u03B7\u03B8\u03BF\u03CD\u03BD, \u03BA\u03B1\u03B8\u03CE\u03C2 \u03BF\u03B9 \u03C0\u03B5\u03C1\u03B9\u03C3\u03C3\u03CC\u03C4\u03B5\u03C1\u03B5\u03C2 \u03B3\u03C5\u03BD\u03B1\u03AF\u03BA\u03B5\u03C2 \u03C6\u03C4\u03AC\u03BD\u03BF\u03C5\u03BD \u03C3\u03C4\u03B7\u03BD \u03B1\u03BD\u03B1\u03C0\u03B1\u03C1\u03B1\u03B3\u03C9\u03B3\u03B9\u03BA\u03AE \u03B7\u03BB\u03B9\u03BA\u03AF\u03B1 \u03C7\u03C9\u03C1\u03AF\u03C2 \u03BD\u03B1 \u03AD\u03C7\u03BF\u03C5\u03BD \u03B5\u03BC\u03B2\u03BF\u03BB\u03B9\u03B1\u03C3\u03C4\u03B5\u03AF \u03AE \u03BD\u03B1 \u03AD\u03C7\u03BF\u03C5\u03BD \u03B5\u03BA\u03C4\u03B5\u03B8\u03B5\u03AF \u03C3\u03C4\u03B7\u03BD \u03B1\u03C3\u03B8\u03AD\u03BD\u03B5\u03B9\u03B1. \u03A9\u03C2 \u03B5\u03BA \u03C4\u03BF\u03CD\u03C4\u03BF\u03C5, \u03B5\u03AF\u03BD\u03B1\u03B9 \u03C3\u03B7\u03BC\u03B1\u03BD\u03C4\u03B9\u03BA\u03CC \u03BD\u03B1 \u03B5\u03BC\u03B2\u03BF\u03BB\u03B9\u03AC\u03B6\u03B5\u03C4\u03B1\u03B9 \u03C0\u03BF\u03C3\u03BF\u03C3\u03C4\u03CC \u03BC\u03B5\u03B3\u03B1\u03BB\u03CD\u03C4\u03B5\u03C1\u03BF \u03B1\u03C0\u03CC \u03C4\u03BF 80% \u03C4\u03BF\u03C5 \u03C0\u03BB\u03B7\u03B8\u03C5\u03C3\u03BC\u03BF\u03CD. \u039F \u03A0\u03B1\u03B3\u03BA\u03CC\u03C3\u03BC\u03B9\u03BF\u03C2 \u039F\u03C1\u03B3\u03B1\u03BD\u03B9\u03C3\u03BC\u03CC\u03C2 \u03A5\u03B3\u03B5\u03AF\u03B1\u03C2 (\u03A0\u039F\u03A5) \u03C3\u03C5\u03BD\u03B9\u03C3\u03C4\u03AC \u03BD\u03B1 \u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03B5\u03C4\u03B1\u03B9 \u03C4\u03BF \u03B5\u03BC\u03B2\u03CC\u03BB\u03B9\u03BF \u03C4\u03B7\u03C2 \u03B5\u03C1\u03C5\u03B8\u03C1\u03AC\u03C2 \u03C3\u03C4\u03BF\u03C5\u03C2 \u03B5\u03BC\u03B2\u03BF\u03BB\u03B9\u03B1\u03C3\u03BC\u03BF\u03CD\u03C2 \u03C1\u03BF\u03C5\u03C4\u03AF\u03BD\u03B1\u03C2. \u0391\u03BD \u03B4\u03B5\u03BD \u03AD\u03C7\u03BF\u03C5\u03BD \u03B5\u03BC\u03B2\u03BF\u03BB\u03B9\u03B1\u03C3\u03C4\u03B5\u03AF \u03CC\u03BB\u03BF\u03B9 \u03BF\u03B9 \u03AC\u03BD\u03B8\u03C1\u03C9\u03C0\u03BF\u03B9, \u03C4\u03CC\u03C4\u03B5 \u03B8\u03B1 \u03C0\u03C1\u03AD\u03C0\u03B5\u03B9 \u03BD\u03B1 \u03B5\u03BC\u03B2\u03BF\u03BB\u03B9\u03AC\u03B6\u03BF\u03BD\u03C4\u03B1\u03B9 \u03C4\u03BF\u03C5\u03BB\u03AC\u03C7\u03B9\u03C3\u03C4\u03BF\u03BD \u03BF\u03B9 \u03B3\u03C5\u03BD\u03B1\u03AF\u03BA\u03B5\u03C2 \u03C3\u03B5 \u03B1\u03BD\u03B1\u03C0\u03B1\u03C1\u03B1\u03B3\u03C9\u03B3\u03B9\u03BA\u03AE \u03B7\u03BB\u03B9\u03BA\u03AF\u03B1. \u0394\u03B5\u03BD \u03C0\u03C1\u03AD\u03C0\u03B5\u03B9 \u03BD\u03B1 \u03C7\u03BF\u03C1\u03B7\u03B3\u03B5\u03AF\u03C4\u03B1\u03B9 \u03C3\u03B5 \u03AD\u03B3\u03BA\u03C5\u03B5\u03C2 \u03B3\u03C5\u03BD\u03B1\u03AF\u03BA\u03B5\u03C2 \u03AE \u03C3\u03B5 \u03AC\u03C4\u03BF\u03BC\u03B1 \u03BC\u03B5 \u03C0\u03BF\u03BB\u03CD \u03BA\u03B1\u03BA\u03AE \u03BB\u03B5\u03B9\u03C4\u03BF\u03C5\u03C1\u03B3\u03AF\u03B1 \u03C4\u03BF\u03C5 \u03B1\u03BD\u03BF\u03C3\u03BF\u03C0\u03BF\u03B9\u03B7\u03C4\u03B9\u03BA\u03BF\u03CD. \u0395\u03BD\u03CE \u03C3\u03C5\u03C7\u03BD\u03AC \u03B1\u03C0\u03B1\u03B9\u03C4\u03B5\u03AF\u03C4\u03B1\u03B9 \u03BC\u03CC\u03BD\u03BF \u03BC\u03AF\u03B1 \u03B4\u03CC\u03C3\u03B7 \u03B3\u03B9\u03B1 \u03BD\u03B1 \u03B4\u03B9\u03B1\u03C3\u03C6\u03B1\u03BB\u03B9\u03C3\u03C4\u03B5\u03AF \u03B7 \u03B4\u03B9\u03B1 \u03B2\u03AF\u03BF\u03C5 \u03C0\u03C1\u03BF\u03C3\u03C4\u03B1\u03C3\u03AF\u03B1, \u03C0\u03BF\u03BB\u03BB\u03AD\u03C2 \u03C6\u03BF\u03C1\u03AD\u03C2 \u03C7\u03BF\u03C1\u03B7\u03B3\u03BF\u03CD\u03BD\u03C4\u03B1\u03B9 \u03B4\u03CD\u03BF \u03B4\u03CC\u03C3\u03B5\u03B9\u03C2. \u039F\u03B9 \u03B1\u03BD\u03B5\u03C0\u03B9\u03B8\u03CD\u03BC\u03B7\u03C4\u03B5\u03C2 \u03B5\u03BD\u03AD\u03C1\u03B3\u03B5\u03B9\u03B5\u03C2 \u03B5\u03AF\u03BD\u03B1\u03B9 \u03B3\u03B5\u03BD\u03B9\u03BA\u03AC \u03AE\u03C0\u03B9\u03B5\u03C2. \u03A3\u03B5 \u03B1\u03C5\u03C4\u03AD\u03C2 \u03BC\u03C0\u03BF\u03C1\u03B5\u03AF \u03BD\u03B1 \u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03B5\u03C4\u03B1\u03B9 \u03C0\u03C5\u03C1\u03B5\u03C4\u03CC\u03C2, \u03B5\u03BE\u03B1\u03BD\u03B8\u03AE\u03BC\u03B1\u03C4\u03B1, \u03C0\u03CC\u03BD\u03BF\u03C2 \u03BA\u03B1\u03B9 \u03B5\u03C1\u03C5\u03B8\u03C1\u03CC\u03C4\u03B7\u03C4\u03B1 \u03C3\u03C4\u03BF \u03C3\u03B7\u03BC\u03B5\u03AF\u03BF \u03C4\u03B7\u03C2 \u03AD\u03BD\u03B5\u03C3\u03B7\u03C2. \u039C\u03AF\u03B1 \u03AD\u03C9\u03C2 \u03C4\u03C1\u03B5\u03B9\u03C2 \u03B5\u03B2\u03B4\u03BF\u03BC\u03AC\u03B4\u03B5\u03C2 \u03BC\u03B5\u03C4\u03AC \u03C4\u03BF\u03BD \u03B5\u03BC\u03B2\u03BF\u03BB\u03B9\u03B1\u03C3\u03BC\u03CC \u03B3\u03C5\u03BD\u03B1\u03B9\u03BA\u03CE\u03BD, \u03B5\u03BD\u03B4\u03AD\u03C7\u03B5\u03C4\u03B1\u03B9 \u03BD\u03B1 \u03B1\u03BD\u03B1\u03C6\u03B5\u03C1\u03B8\u03B5\u03AF \u03C0\u03CC\u03BD\u03BF\u03C2 \u03C3\u03C4\u03B9\u03C2 \u03B1\u03C1\u03B8\u03C1\u03CE\u03C3\u03B5\u03B9\u03C2. \u03A3\u03C0\u03AC\u03BD\u03B9\u03B1 \u03B5\u03BA\u03B4\u03B7\u03BB\u03CE\u03BD\u03BF\u03BD\u03C4\u03B1\u03B9 \u03C3\u03BF\u03B2\u03B1\u03C1\u03AD\u03C2 \u03B1\u03BB\u03BB\u03B5\u03C1\u03B3\u03AF\u03B5\u03C2. \u03A4\u03BF \u03B5\u03BC\u03B2\u03CC\u03BB\u03B9\u03BF \u03C4\u03B7\u03C2 \u03B5\u03C1\u03C5\u03B8\u03C1\u03AC\u03C2 \u03B5\u03AF\u03BD\u03B1\u03B9 \u03B4\u03B9\u03B1\u03B8\u03AD\u03C3\u03B9\u03BC\u03BF \u03B5\u03AF\u03C4\u03B5 \u03BC\u03B5\u03BC\u03BF\u03BD\u03C9\u03BC\u03AD\u03BD\u03B1 \u03B5\u03AF\u03C4\u03B5 \u03C3\u03B5 \u03C3\u03C5\u03BD\u03B4\u03C5\u03B1\u03C3\u03BC\u03CC \u03BC\u03B5 \u03AC\u03BB\u03BB\u03B1 \u03B5\u03BC\u03B2\u03CC\u03BB\u03B9\u03B1. \u03A3\u03C4\u03BF\u03C5\u03C2 \u03C3\u03C5\u03BD\u03B4\u03C5\u03B1\u03C3\u03BC\u03BF\u03CD\u03C2 \u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03BF\u03BD\u03C4\u03B1\u03B9 \u03C4\u03B1 \u03B5\u03BC\u03B2\u03CC\u03BB\u03B9\u03B1 \u03B9\u03BB\u03B1\u03C1\u03AC\u03C2 \u03BA\u03B1\u03B9 \u03C0\u03B1\u03C1\u03C9\u03C4\u03AF\u03C4\u03B9\u03B4\u03B1\u03C2 \u03BA\u03B1\u03B8\u03CE\u03C2 \u03BA\u03B1\u03B9 \u03C4\u03BF \u03B5\u03BC\u03B2\u03CC\u03BB\u03B9\u03BF \u03B9\u03BB\u03B1\u03C1\u03AC\u03C2, \u03C0\u03B1\u03C1\u03C9\u03C4\u03AF\u03C4\u03B9\u03B4\u03B1\u03C2 \u03BA\u03B1\u03B9 \u03B1\u03BD\u03B5\u03BC\u03BF\u03B2\u03BB\u03BF\u03B3\u03B9\u03AC\u03C2. \u03A4\u03BF \u03B5\u03BC\u03B2\u03CC\u03BB\u03B9\u03BF \u03C4\u03B7\u03C2 \u03B5\u03C1\u03C5\u03B8\u03C1\u03AC\u03C2 \u03BA\u03C5\u03BA\u03BB\u03BF\u03C6\u03CC\u03C1\u03B7\u03C3\u03B5 \u03B3\u03B9\u03B1 \u03C0\u03C1\u03CE\u03C4\u03B7 \u03C6\u03BF\u03C1\u03AC \u03C4\u03BF 1969. \u03A0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03B5\u03C4\u03B1\u03B9 \u03C3\u03C4\u03BF\u03BD \u03A0\u03C1\u03CC\u03C4\u03C5\u03C0\u03BF \u039A\u03B1\u03C4\u03AC\u03BB\u03BF\u03B3\u03BF \u0392\u03B1\u03C3\u03B9\u03BA\u03CE\u03BD \u03A6\u03B1\u03C1\u03BC\u03AC\u03BA\u03C9\u03BD \u03C4\u03BF\u03C5 \u03A0\u03B1\u03B3\u03BA\u03CC\u03C3\u03BC\u03B9\u03BF\u03C5 \u039F\u03C1\u03B3\u03B1\u03BD\u03B9\u03C3\u03BC\u03BF\u03CD \u03A5\u03B3\u03B5\u03AF\u03B1\u03C2, \u03AD\u03BD\u03B1\u03BD \u03BA\u03B1\u03C4\u03AC\u03BB\u03BF\u03B3\u03BF \u03BC\u03B5 \u03C4\u03B9\u03C2 \u03C0\u03B9\u03BF \u03C3\u03B7\u03BC\u03B1\u03BD\u03C4\u03B9\u03BA\u03AD\u03C2 \u03C6\u03B1\u03C1\u03BC\u03B1\u03BA\u03B5\u03C5\u03C4\u03B9\u03BA\u03AD\u03C2 \u03BF\u03C5\u03C3\u03AF\u03B5\u03C2 \u03C0\u03BF\u03C5 \u03B5\u03AF\u03BD\u03B1\u03B9 \u03B1\u03C0\u03B1\u03C1\u03B1\u03AF\u03C4\u03B7\u03C4\u03B5\u03C2 \u03C3\u03B5 \u03AD\u03BD\u03B1 . \u0391\u03C0\u03CC \u03C4\u03BF 2009 \u03C0\u03B5\u03C1\u03B9\u03C3\u03C3\u03CC\u03C4\u03B5\u03C1\u03B5\u03C2 \u03B1\u03C0\u03CC 130 \u03C7\u03CE\u03C1\u03B5\u03C2 \u03C4\u03BF \u03AD\u03C7\u03BF\u03C5\u03BD \u03B5\u03BD\u03C4\u03AC\u03BE\u03B5\u03B9 \u03C3\u03C4\u03BF\u03C5\u03C2 \u03B5\u03BC\u03B2\u03BF\u03BB\u03B9\u03B1\u03C3\u03BC\u03BF\u03CD\u03C2 \u03C1\u03BF\u03C5\u03C4\u03AF\u03BD\u03B1\u03C2.\u03A4\u03BF 2014 \u03C4\u03BF \u03BA\u03CC\u03C3\u03C4\u03BF\u03C2 \u03C7\u03BF\u03BD\u03B4\u03C1\u03B9\u03BA\u03AE\u03C2 \u03B3\u03B9\u03B1 \u03C4\u03BF \u03B5\u03BC\u03B2\u03CC\u03BB\u03B9\u03BF MMR \u03B1\u03BD\u03B5\u03C1\u03C7\u03CC\u03C4\u03B1\u03BD \u03C3\u03B5 0,24 \u03B4\u03BF\u03BB\u03AC\u03C1\u03B9\u03B1 \u03B1\u03BD\u03AC \u03B4\u03CC\u03C3\u03B7. \u03A3\u03C4\u03B9\u03C2 \u0397\u03BD\u03C9\u03BC\u03AD\u03BD\u03B5\u03C2 \u03A0\u03BF\u03BB\u03B9\u03C4\u03B5\u03AF\u03B5\u03C2 \u03C4\u03BF \u03BA\u03CC\u03C3\u03C4\u03BF\u03C2 \u03BA\u03C5\u03BC\u03B1\u03AF\u03BD\u03B5\u03C4\u03B1\u03B9 \u03BC\u03B5\u03C4\u03B1\u03BE\u03CD 50 \u03BA\u03B1\u03B9 100 \u03B4\u03BF\u03BB\u03B1\u03C1\u03AF\u03C9\u03BD."@el . . "\u98A8\u75B9\u30EF\u30AF\u30C1\u30F3"@ja . . "\u5FB7\u570B\u9EBB\u75B9\u75AB\u82D7\uFF08\u82F1\u6587\uFF1ARubella vaccine\uFF09\uFF0C\u662F\u4E00\u7A2E\u7528\u65BC\u9810\u9632\u98A8\u75B9\u7684\u75AB\u82D7\u3002\u5176\u6548\u529B\u59CB\u65BC\u55AE\u4E00\u5291\u91CF\u5F8C\u7684\u5169\u9031\uFF0C\u800C\u4E14\u5927\u7D0495%\u7684\u4EBA\u6703\u5F97\u5230\u514D\u75AB\u529B\u3002 \u6709\u9AD8\u514D\u75AB\u63A5\u7A2E\u7387\u7684\u570B\u5BB6\u4E0D\u518D\u6709\u98A8\u75B9\u53CA\u7684\u6848\u4F8B\uFF0C\u7576\u4EBA\u53E3\u4E2D\u5152\u7AE5\u514D\u75AB\u63A5\u7A2E\u6C34\u5E73\u8F03\u4F4E\u6642\uFF0C\u5148\u5929\u6027\u98A8\u75B9\u75C5\u6BD2\u7684\u767C\u75C5\u7387\u53EF\u80FD\u6703\u589E\u52A0\uFF0C\u800C\u4E14\u8D8A\u4F86\u8D8A\u591A\u7684\u5A66\u5973\u5230\u9069\u9F61\u751F\u80B2\u671F\u4F9D\u7136\u672A\u63A5\u7A2E\u75AB\u82D7\u6216\u66B4\u9732\u65BC\u75BE\u75C5\u4E0B\u3002\u56E0\u6B64\uFF0C\u8B93\u8D85\u904E80%\u7684\u4EBA\u63A5\u7A2E\u75AB\u82D7\u662F\u975E\u5E38\u91CD\u8981\u7684\u3002 \u4E16\u754C\u885B\u751F\u7D44\u7E54\u5EFA\u8B70\u5C07\u5FB7\u570B\u9EBB\u75B9\u75AB\u82D7\u7D0D\u5165\u3002 \u82E5\u7121\u6CD5\u5168\u6C11\u63A5\u7A2E\u75AB\u82D7\uFF0C\u81F3\u5C11\u9069\u9F61\u751F\u80B2\u7684\u5973\u6027\u61C9\u8A72\u63A5\u7A2E\u75AB\u82D7\uFF0C \u800C\u61F7\u5B55\u6216\u514D\u75AB\u529B\u975E\u5E38\u5DEE\u7684\u4EBA\u5247\u4E0D\u61C9\u63A5\u7A2E\u75AB\u82D7\u3002 \u96D6\u7136\u55AE\u4E00\u5291\u91CF\u901A\u5E38\u80FD\u9054\u5230\u7D42\u8EAB\u4FDD\u8B77\u7684\u6548\u679C\uFF0C\u4F46\u901A\u5E38\u6703\u7D66\u4E88\u96D9\u5291\u91CF\u3002 \u5176\u526F\u4F5C\u7528\u4E00\u822C\u662F\u6EAB\u548C\u7684\uFF0C \u5305\u62EC\u767C\u71D2\u3001\u5728\u6CE8\u5C04\u75AB\u82D7\u90E8\u4F4D\u8D77\u75B9\u5B50\u3001\u75BC\u75DB\u8207\u767C\u7D05\u3002 \u5973\u6027\u5728\u63A5\u7A2E\u75AB\u82D7\u5F8C\u4E00\u81F3\u4E09\u9031\u53EF\u80FD\u6703\u6709\u95DC\u7BC0\u75DB\u3002 \u5F88\u5C11\u6703\u6709\u56B4\u91CD\u904E\u654F\u53CD\u61C9\u3002 \u5FB7\u570B\u9EBB\u75B9\u75AB\u82D7\u5728\u4F7F\u7528\u4E0A\u53EF\u4EE5\u55AE\u7368\u4F7F\u7528\u6216\u8207\u5176\u4ED6\u75AB\u82D7\u5408\u4F75\u4F7F\u7528\uFF0C \u5176\u6DF7\u5408\u75AB\u82D7\u5305\u62EC\u5408\u4F75\u9EBB\u75B9\u3001\u816E\u817A\u708E\u75AB\u82D7\uFF08\u9EBB\u816E\u98CE\u4E09\u8054\u75AB\u82D7\uFF09\u4EE5\u53CA\u5408\u4F75\u9EBB\u75B9\u3001\u816E\u817A\u708E\u3001\u6C34\u75D8\u75AB\u82D7\uFF08\uFF09\u3002 \u5FB7\u570B\u9EBB\u75B9\u75AB\u82D7\u57281969\u5E74\u9996\u6B21\u7372\u5F97\u8A31\u53EF\uFF0C \u662F\u5728\u4E16\u754C\u885B\u751F\u7D44\u7E54\u57FA\u672C\u85E5\u7269\u6A19\u6E96\u6E05\u55AE\u4E2D\uFF0C\u91AB\u7642\u885B\u751F\u7CFB\u7D71\u6240\u9700\u6700\u6709\u6548\u4EE5\u53CA\u6700\u5B89\u5168\u7684\u85E5\u7269\u3002 2009\u5E74\u7684\u6642\u5019\uFF0C\u8D85\u904E130\u500B\u570B\u5BB6\u5C07\u5176\u7D0D\u5165\u8A72\u570B\u7684\u5E38\u898F\u63A5\u7A2E\u75AB\u82D7\u3002 \u9EBB\u75B9\u3001\u816E\u817A\u708E\u3001\u5FB7\u570B\u9EBB\u75B9\u6DF7\u5408\u75AB\u82D72014\u5E74\u5728\u767C\u5C55\u4E2D\u570B\u5BB6\u7684\u6279\u767C\u6210\u672C\u70BA\u6BCF\u5291\u91CF0.24\u7F8E\u5143\u3002 \u5728\u7F8E\u570B\u9700\u82B1\u8CBB50\u5230100\u7F8E\u5143\u3002"@zh . "a601176" . "\uD48D\uC9C4 \uBC31\uC2E0(\uC601\uC5B4: Rubella vaccine)\uC740 \uD48D\uC9C4\uC5D0 \uAC10\uC5FC\uB418\uC9C0 \uC54A\uAE30 \uC704\uD574 \uC0AC\uC6A9\uD558\uB294 \uBC31\uC2E0\uC774\uB2E4. \uB2E8\uC77C \uC811\uC885\uC73C\uB85C \uC57D 2\uC8FC \uD6C4\uC5D0 \uD6A8\uACFC\uAC00 \uC2DC\uC791\uB418\uBA70, \uC57D 95%\uC758 \uC0AC\uB78C\uC774 \uBA74\uC5ED\uC774 \uD615\uC131\uB41C\uB2E4. \uC608\uBC29 \uC811\uC885\uB960\uC774 \uB192\uC740 \uAD6D\uAC00\uC5D0\uC11C\uB294 \uB354 \uC774\uC0C1 \uD48D\uC9C4\uC774 \uBC1C\uBCD1\uB418\uC9C0 \uC54A\uB294\uB2E4. \uB530\uB77C\uC11C 80% \uC774\uC0C1\uC758 \uC0AC\uB78C\uB4E4\uC774 \uC608\uBC29\uC811\uC885\uC744 \uBC1B\uB294 \uAC83\uC774 \uC911\uC694\uD558\uB2E4. \uC138\uACC4\uBCF4\uAC74\uAE30\uAD6C \uD544\uC218 \uC758\uC57D\uD488 \uBAA9\uB85D\uC5D0 \uD48D\uC9C4 \uBC31\uC2E0\uC774 \uB4F1\uC7AC\uB418\uC5B4 \uC788\uB2E4. \uC8FC\uBCC0 \uC0AC\uB78C\uB4E4\uC774 \uC608\uBC29 \uC811\uC885\uC744 \uBC1B\uC9C0 \uC54A\uC558\uB2E4\uBA74, \uCD5C\uC18C\uD55C \uAC00\uC784\uAE30 \uC5EC\uC131\uC740 \uC608\uBC29\uC811\uC885\uC744 \uBC1B\uB294 \uAC83\uC774 \uC88B\uB2E4."@ko . . "Il vaccino della rosolia \u00E8 un vaccino che viene utilizzato per prevenire la rosolia. Il vaccino richiede all'incirca due settimane per essere efficace, ed una singola dose \u00E8 sufficiente a rendere immune circa il 95% dei soggetti. Nei paesi che presentano alti tassi di immunizzazione non sono pi\u00F9 presenti casi di rosolia di nuova insorgenza, o di sindrome da rosolia congenita. Laddove il tasso di immunizzazione infantile \u00E8 invece basso, il numero di casi di rosolia congenita \u00E8 destinato ad incrementare per via dell'aumentato numero di donne che raggiungono l'et\u00E0 fertile senza essere state prima vaccinate o esposte al contagio. \u00C8 quindi raccomandato che a ricevere il vaccino sia almeno l'80% della popolazione. L'Organizzazione mondiale della sanit\u00E0 (OMS) ha raccomandato che il vaccino della rosolia sia fra quelli inclusi nella vaccinazione di routine. Laddove non sia possibile vaccinare l'intera popolazione, la priorit\u00E0 \u00E8 che a ricevere il vaccino siano almeno le donne in et\u00E0 fertile. Il vaccino non deve essere somministrato alle donne in gravidanza o ai soggetti immunocompromessi. Sebbene una dose sia generalmente sufficiente a garantire la protezione per tutta la vita, vengono spesso somministrate due dosi. Gli effetti collaterali sono generalmente lievi. Includono febbre, rash cutaneo, dolore e arrossamento nella zona dell'iniezione. Nelle donne \u00E8 talvolta presente dolore articolare a distanza di 1-3 settimane dal momento della vaccinazione. L'anafilassi \u00E8 invece rara. Il vaccino della rosolia \u00E8 disponibile da solo o in combinazione con altri vaccini. Le combinazioni includono quella con il vaccino del morbillo, con quello della parotite (vaccino MPR), e con quello del morbillo, parotite e varicella (vaccino MPRV). Il primo vaccino della rosolia \u00E8 stato approvato nel 1969. Fa parte della Lista dei Farmaci Essenziali dell'Organizzazione Mondiale della Sanit\u00E0, ovvero i farmaci di maggiore importanza richiesti in un sistema sanitario di base. Nel 2009 circa 130 paesi lo hanno incluso nella loro vaccinazione di routine. Il costo all'ingrosso del vaccino MPR \u00E8 di 0.24 USD per dose nel 2014. Negli Stati Uniti il costo per dose si aggira tra i 50 e i 100 USD."@it . . "Vaksin rubela"@in . "Vaccin contre la rub\u00E9ole"@fr . . . . . . . . "\u98A8\u75B9\u30EF\u30AF\u30C1\u30F3\uFF08\u3075\u3046\u3057\u3093\u30EF\u30AF\u30C1\u30F3\uFF09\u3068\u306F\u3001\u98A8\u75B9\u306E\u4E88\u9632\u306B\u7528\u3044\u3089\u308C\u308B\u30EF\u30AF\u30C1\u30F3\u3067\u3042\u308B\u3002"@ja . "BJ01"@en . . . . . . . . . "\u0644\u0642\u0627\u062D \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: \u0644\u0642\u0627\u062D \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629)\u0647\u0648 \u0644\u0642\u0627\u062D \u064A\u0633\u062A\u062E\u062F\u0645 \u0644\u0644\u0648\u0642\u0627\u064A\u0629 \u0645\u0646 \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629. \u062A\u0628\u062F\u0623 \u0641\u0639\u0627\u0644\u064A\u062A\u0647 \u0628\u0639\u062F \u0623\u0633\u0628\u0648\u0639\u064A\u0646 \u0645\u0646 \u0627\u0644\u062C\u0631\u0639\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 \u0648\u062A\u0642\u0631\u064A\u0628\u0627\u064F 95% \u0645\u0646 \u0627\u0644\u0623\u0634\u062E\u0627\u0635 \u064A\u0635\u0628\u062D\u0648\u0627 \u0645\u062D\u0635\u0646\u064A\u0646 \u0636\u062F \u0627\u0644\u0639\u062F\u0648\u0649. \u0627\u0644\u0628\u0644\u062F\u0627\u0646 \u0630\u0627\u062A \u0645\u0639\u062F\u0644\u0627\u062A \u0627\u0644\u062A\u062D\u0635\u064A\u0646 \u0627\u0644\u0645\u0631\u062A\u0641\u0639\u0629 \u0644\u0645 \u062A\u0639\u062F \u062A\u0631\u0649 \u062D\u0627\u0644\u0627\u062A \u0627\u0644\u0625\u0635\u0627\u0628\u0629 \u0628\u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 \u0623\u0648 \u0645\u062A\u0644\u0627\u0632\u0645\u0629 \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 \u0627\u0644\u062E\u0644\u0642\u064A\u0629. \u0639\u0646\u062F\u0645\u0627 \u064A\u0643\u0648\u0646 \u0645\u0633\u062A\u0648\u0649 \u0627\u0644\u0645\u0646\u0627\u0639\u0629 \u0636\u062F \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 \u0639\u0646\u062F \u0627\u0644\u0623\u0637\u0641\u0627\u0644 \u0645\u0646\u062E\u0641\u0636 \u0645\u0646 \u0627\u0644\u0645\u062D\u062A\u0645\u0644 \u0623\u0646 \u062A\u0631\u062A\u0641\u0639 \u0645\u0639\u062F\u0644\u0627\u062A \u0627\u0644\u0635\u0627\u0628\u0629 \u0628\u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 \u0627\u0644\u062E\u0644\u0642\u064A\u0629 \u062C\u064A\u062B \u064A\u0632\u062F\u0627\u062F \u0639\u062F\u062F \u0627\u0644\u0646\u0633\u0627\u0621 \u0627\u0644\u0644\u0648\u0627\u062A\u064A \u064A\u0635\u0644\u0646 \u0644\u0633\u0646 \u0627\u0644\u0625\u0646\u062C\u0627\u0628 \u062F\u0648\u0646 \u0623\u062E\u062F \u0627\u0644\u062A\u0637\u0639\u064A\u0645 \u0623\u0648 \u0627\u0644\u062A\u0639\u0631\u0636 \u0644\u0644\u0645\u0631\u0636. \u0644\u0630\u0644\u0643\u060C \u0645\u0646 \u0627\u0644\u0645\u0647\u0645 \u0623\u0646 \u064A\u0643\u0648\u0646 \u0623\u0643\u062B\u0631 \u0645\u0646 80% \u0645\u0646 \u0627\u0644\u0646\u0627\u0633 \u062A\u0645 \u062A\u0637\u0639\u064A\u0645\u0647\u0645.\u0623\u0648\u0635\u062A \u0645\u0646\u0638\u0645\u0629 \u0627\u0644\u0635\u062D\u0629 \u0627\u0644\u0639\u0627\u0644\u0645\u064A\u0629 \u0628\u0625\u062F\u0631\u0627\u062C \u0644\u0642\u0627\u062D \u0627\u0644\u062D\u0635\u0628\u0629 \u0627\u0644\u0623\u0644\u0645\u0627\u0646\u064A\u0629 \u0636\u0645\u0646 \u0627\u0644\u0644\u0642\u0627\u062D\u0627\u062A \u0627\u0644\u0631\u0648\u062A\u064A\u0646\u064A\u0629. \u0625\u0630\u0627 \u0644\u0645 \u064A\u062A\u0645 \u062A\u0637\u0639\u064A\u0645 \u062C\u0645\u064A\u0639 \u0627\u0644\u0646\u0627\u0633 \u0639\u0644\u0649 \u0627\u0644\u0623\u0642\u0644 \u064A\u062C\u0628 \u062A\u0637\u0639\u064A\u0645 \u0627\u0644\u0646\u0633\u0627\u0621 \u0641\u064A \u0633\u0646 \u0627\u0644\u0625\u0646\u062C\u0627\u0628. \u0648\u0644\u0627 \u064A\u062C\u0628 \u0623\u0639\u0637\u0627\u0626\u0647 \u0644\u0644\u0646\u0633\u0627\u0621 \u062E\u0644\u0627\u0644 \u0627\u0644\u062D\u0645\u0644 \u0623\u0648 \u0627\u0644\u0623\u0634\u062E\u0627\u0635 \u0630\u0648\u064A \u0627\u0644\u0645\u0646\u0627\u0639\u0629 \u0627\u0644\u0636\u0639\u064A\u0641\u0629. \u0628\u064A\u0646\u0645\u0627 \u062A\u0643\u0641\u064A \u062C\u0631\u0639\u0629 \u0648\u0627\u062D\u062F"@ar . . . . "\u5FB7\u570B\u9EBB\u75B9\u75AB\u82D7\uFF08\u82F1\u6587\uFF1ARubella vaccine\uFF09\uFF0C\u662F\u4E00\u7A2E\u7528\u65BC\u9810\u9632\u98A8\u75B9\u7684\u75AB\u82D7\u3002\u5176\u6548\u529B\u59CB\u65BC\u55AE\u4E00\u5291\u91CF\u5F8C\u7684\u5169\u9031\uFF0C\u800C\u4E14\u5927\u7D0495%\u7684\u4EBA\u6703\u5F97\u5230\u514D\u75AB\u529B\u3002 \u6709\u9AD8\u514D\u75AB\u63A5\u7A2E\u7387\u7684\u570B\u5BB6\u4E0D\u518D\u6709\u98A8\u75B9\u53CA\u7684\u6848\u4F8B\uFF0C\u7576\u4EBA\u53E3\u4E2D\u5152\u7AE5\u514D\u75AB\u63A5\u7A2E\u6C34\u5E73\u8F03\u4F4E\u6642\uFF0C\u5148\u5929\u6027\u98A8\u75B9\u75C5\u6BD2\u7684\u767C\u75C5\u7387\u53EF\u80FD\u6703\u589E\u52A0\uFF0C\u800C\u4E14\u8D8A\u4F86\u8D8A\u591A\u7684\u5A66\u5973\u5230\u9069\u9F61\u751F\u80B2\u671F\u4F9D\u7136\u672A\u63A5\u7A2E\u75AB\u82D7\u6216\u66B4\u9732\u65BC\u75BE\u75C5\u4E0B\u3002\u56E0\u6B64\uFF0C\u8B93\u8D85\u904E80%\u7684\u4EBA\u63A5\u7A2E\u75AB\u82D7\u662F\u975E\u5E38\u91CD\u8981\u7684\u3002 \u4E16\u754C\u885B\u751F\u7D44\u7E54\u5EFA\u8B70\u5C07\u5FB7\u570B\u9EBB\u75B9\u75AB\u82D7\u7D0D\u5165\u3002 \u82E5\u7121\u6CD5\u5168\u6C11\u63A5\u7A2E\u75AB\u82D7\uFF0C\u81F3\u5C11\u9069\u9F61\u751F\u80B2\u7684\u5973\u6027\u61C9\u8A72\u63A5\u7A2E\u75AB\u82D7\uFF0C \u800C\u61F7\u5B55\u6216\u514D\u75AB\u529B\u975E\u5E38\u5DEE\u7684\u4EBA\u5247\u4E0D\u61C9\u63A5\u7A2E\u75AB\u82D7\u3002 \u96D6\u7136\u55AE\u4E00\u5291\u91CF\u901A\u5E38\u80FD\u9054\u5230\u7D42\u8EAB\u4FDD\u8B77\u7684\u6548\u679C\uFF0C\u4F46\u901A\u5E38\u6703\u7D66\u4E88\u96D9\u5291\u91CF\u3002 \u5176\u526F\u4F5C\u7528\u4E00\u822C\u662F\u6EAB\u548C\u7684\uFF0C \u5305\u62EC\u767C\u71D2\u3001\u5728\u6CE8\u5C04\u75AB\u82D7\u90E8\u4F4D\u8D77\u75B9\u5B50\u3001\u75BC\u75DB\u8207\u767C\u7D05\u3002 \u5973\u6027\u5728\u63A5\u7A2E\u75AB\u82D7\u5F8C\u4E00\u81F3\u4E09\u9031\u53EF\u80FD\u6703\u6709\u95DC\u7BC0\u75DB\u3002 \u5F88\u5C11\u6703\u6709\u56B4\u91CD\u904E\u654F\u53CD\u61C9\u3002 \u5FB7\u570B\u9EBB\u75B9\u75AB\u82D7\u5728\u4F7F\u7528\u4E0A\u53EF\u4EE5\u55AE\u7368\u4F7F\u7528\u6216\u8207\u5176\u4ED6\u75AB\u82D7\u5408\u4F75\u4F7F\u7528\uFF0C \u5176\u6DF7\u5408\u75AB\u82D7\u5305\u62EC\u5408\u4F75\u9EBB\u75B9\u3001\u816E\u817A\u708E\u75AB\u82D7\uFF08\u9EBB\u816E\u98CE\u4E09\u8054\u75AB\u82D7\uFF09\u4EE5\u53CA\u5408\u4F75\u9EBB\u75B9\u3001\u816E\u817A\u708E\u3001\u6C34\u75D8\u75AB\u82D7\uFF08\uFF09\u3002 \u5FB7\u570B\u9EBB\u75B9\u75AB\u82D7\u57281969\u5E74\u9996\u6B21\u7372\u5F97\u8A31\u53EF\uFF0C \u662F\u5728\u4E16\u754C\u885B\u751F\u7D44\u7E54\u57FA\u672C\u85E5\u7269\u6A19\u6E96\u6E05\u55AE\u4E2D\uFF0C\u91AB\u7642\u885B\u751F\u7CFB\u7D71\u6240\u9700\u6700\u6709\u6548\u4EE5\u53CA\u6700\u5B89\u5168\u7684\u85E5\u7269\u3002 2009\u5E74\u7684\u6642\u5019\uFF0C\u8D85\u904E130\u500B\u570B\u5BB6\u5C07\u5176\u7D0D\u5165\u8A72\u570B\u7684\u5E38\u898F\u63A5\u7A2E\u75AB\u82D7\u3002 \u9EBB\u75B9\u3001\u816E\u817A\u708E\u3001\u5FB7\u570B\u9EBB\u75B9\u6DF7\u5408\u75AB\u82D72014\u5E74\u5728\u767C\u5C55\u4E2D\u570B\u5BB6\u7684\u6279\u767C\u6210\u672C\u70BA\u6BCF\u5291\u91CF0.24\u7F8E\u5143\u3002 \u5728\u7F8E\u570B\u9700\u82B1\u8CBB50\u5230100\u7F8E\u5143\u3002"@zh .